These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 5587378)
1. Hormofort, a new Hungarian gestagen, in obstetrical and gynaecological practice. Molnár G; Kiss E Ther Hung; 1967; 15(4):163-4. PubMed ID: 5587378 [No Abstract] [Full Text] [Related]
2. [On the effectiveness of a new gestagen in the treatment of bleeding anomalies. A clinical contribution to the problem of oral gestagen therapie]. Thewanger W Wien Klin Wochenschr; 1965 Jun; 77(25):468-9. PubMed ID: 5319349 [No Abstract] [Full Text] [Related]
6. The use of Ro 4-8347 in amenorrhea and anovulation. Polishuk WZ; Schechter A; Kozminski T Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):565-74. PubMed ID: 5510180 [No Abstract] [Full Text] [Related]
7. [Treatment of endocrine sterility with retroprogesterone Ro 4-8347]. Stamm O; Gerhard I; Zarro D Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):472-80. PubMed ID: 5279914 [No Abstract] [Full Text] [Related]
8. Iatrogenic disease in obstetrics and gynaecology. Camilleri AP Practitioner; 1970 Mar; 204(221):406-11. PubMed ID: 5434400 [No Abstract] [Full Text] [Related]
9. The treatment of monophasic cycles with the retroprogesterone Ro 4-8347. Taubert HD; Jürgensen O Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):503-11. PubMed ID: 4251825 [No Abstract] [Full Text] [Related]
10. Clinical studies on bis-(para-acetoxyphenyl)-cyclohexylidenemethane (Sexovid) and on 6-chloro-9 beta,10 alpha-pregna-1,4,6-triene-3,20-dione (Ro 4-8347). Neale C; Bettendorf G; Treu G Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):545-50. PubMed ID: 5510179 [No Abstract] [Full Text] [Related]
11. [Therapy of severe menstruation disorders with retrosteroid Ro 4-8347]. Hauser GA Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):490-502. PubMed ID: 5510175 [No Abstract] [Full Text] [Related]
12. [Indications for the treatment with so-called ovulation inhibitors]. Haller J Dtsch Med Wochenschr; 1966 Sep; 91(37):1653-5. PubMed ID: 5946154 [No Abstract] [Full Text] [Related]
13. [Experiences with a gestagen-estrogen combination in general practice]. Werner M Z Allgemeinmed; 1970 Mar; 46(7):375-6. PubMed ID: 5442965 [No Abstract] [Full Text] [Related]
14. [Clinical use of gestagen steroids]. Bergsjo P Tidsskr Nor Laegeforen; 1968 Dec; 88(23):2167-75. PubMed ID: 5710335 [No Abstract] [Full Text] [Related]
15. [Methyl-hydroxyprogesterone acetate in association with ethinyl estradiol in obstetrics and gynecology]. Avezzù G; Vinci GW Quad Clin Ostet Ginecol; 1966 Jan; 21(1):23-39. PubMed ID: 5959285 [No Abstract] [Full Text] [Related]
16. Significance of Hormofort therapy and hormone-cytological examinations in cyclic disorders in puberty. Boros S; Molnár G Ther Hung; 1969; 17(1):30-5. PubMed ID: 5807605 [No Abstract] [Full Text] [Related]
17. Regulation of disorders of the female cycle. Tillinger KG Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):458-62. PubMed ID: 5510172 [No Abstract] [Full Text] [Related]
18. [The action of progesterone on uterine motoricity. Therapeutic deductions]. Crainicianu A Rev Fr Gynecol Obstet; 1967 Jun; 62(6):295-301. PubMed ID: 5630242 [No Abstract] [Full Text] [Related]
19. [Study of therpaeutic indications of Ro 4-8347]. Guéguen J Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):526-40. PubMed ID: 5510178 [No Abstract] [Full Text] [Related]
20. [Effect of synthetic gestagen on the function of the corpus luteum and the placenta]. Ishibashi T Nihon Sanka Fujinka Gakkai Zasshi; 1965 Jul; 17(7):605-13. PubMed ID: 5895217 [No Abstract] [Full Text] [Related] [Next] [New Search]